This report marks the beginning of a long-term, longitudinal study of the migraine patient. Patients Try Multiple Treatment Options, But Most Remain Unsatisfied Migraine sufferers often rely on a complex regimen of various prescription and OTC medicines, as well as alternative therapies to prevent or relieve pain. Despite the medical advances of recent years, patients often remain unsatisfied with migraine treatment. Less than half of migraine patients were satisfied with their medical care, with those seeing Neurologists or headache specialists noticeably more satisfied. Even the most innovative products are not thoroughly meeting patient expectations, particularly along the dimensions of recurrence of headaches and prevention.
Many migraine patients face economic barriers in accessing drugs to relieve their headache pain.
Many patients have specific rules about what to take when, often reserving their most effective medicine for the absolute worst headaches. Patients Take the Lead in Defining their Care DrugVoice research reveals that patients are active participants in the migraine care process, and often do not view their physicians as fully understanding their needs. Switching among products is extremely common, as patients look for options that consistently and completely alleviate migraine pain. Many patients are in the driver s seat when it comes to selecting a migraine therapy. A tremendous opportunity exists for pharmaceutical and health care companies to tap into this vein of consumer activism and more thoroughly understand the patient s perspective.